Home / Intelligence / Webinars / Cracking the Code on Generative AI: From Hype to Impact
Available On Demand
Watched our AIML 101 webinar and ready to learn more? Trinity Life Sciences is excited to continue the conversation with our next webinar, which will dive deeper into how pharma companies can move beyond the hype to unlock the value of Generative AI (GenAI).
Join Trinity experts, Steve Laux, VP of Commercial Insights & Advanced Analytics, Nabha Subramanya, VP of Data Science and Patrick Waring, Director of New Products & Strategy, as they sift through all the noise surrounding GenAI and share real-life use cases and practical actions that you should be doing now to drive impact for your organization.
AIML is here. Be ready with Trinity.
Key Webinar Topics
- Examine the current landscape of GenAI in the pharma industry
- Explore real-life, practical use cases of GenAI in pharma, with a focus on what’s working and what’s not
- Address the challenges of implementing GenAI, such as the rapidly changing tech stack
- Prioritize use cases based on their potential value for your organization
- Learn about Trinity’s framework for evaluating and implementing GenAI
Featuring
Steven Laux
Vice President, Analytics &
Head of Generative AI
Nabha Subramanya
Vice President,
Data Science
Patrick Waring
Director,
New Products & Strategy
Complete the form below to view the on-demand webinar
By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.
This webinar will be hosted within the ON24 platform, which requires the usage of Javascript and Cookies. Please see ON24’s Privacy Policy for more information.
*Gartner, Hype Cycle for Life Sciences Commercial Operations, Animesh Gandhi, published 13 August 2024.
GARTNER is a registered trademark and service mark of Gartner and Hype Cycle is a registered trademark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and are used herein with permission. All rights reserved.
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
Related Intelligence
Webinars
Generative AI in Pharma – Five Years From Now
Available On Demand
Generative AI is having a transformative impact on the pharmaceutical industry. Drugmakers are partnering up with companies like Insilico Medicine, Exscientia, BenevolentAI, and more to leverage their respective generative AI-powered platforms and applying them across the pharma value chain: from accelerating drug discovery and optimizing clinical trials, to improving operational efficiencies and enabling personalized treatments […]
Watch Now
Webinars
The Future of Patient Finding
Available On Demand
Patient finding is more than a buzzword. Ready to challenge the status quo? With more data, advancements in AIML and greater access to insights, it is not surprising that patient finding is evolving. Many pharma organizations have deep-rooted ideas about what patient finding requires, but they often miss the opportunity to put the patient at […]
Watch Now
Webinars
Who “Owns” the Customer in Customer Engagement?
Available On Demand
In your company, is it Sales, Marketing, Analytics, Operations, Medical…? If you are struggling to answer this question, you are not alone. With the rising adoption of digital and virtual approaches to customer engagement, companies are facing more complexity in commercialization. Organizations that lack clarity find that achieving the desired impact from customer engagement strategies […]
Watch Now